BOUT - Innovator IBD Breakout Opportunities ETF
The Innovator IBD Breakout Opportunities ETF seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investor's Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the security's recent "resistance level", with consideration for various market conditions.
- Sector
- Financial Services
- Industry
- Asset Management
- Market Cap
- $16.1M
- Beta
- 1.21
- 52-Week Range
- 34.94-47.21
- Dividend Yield
- $0.12
- IPO Date
- Sep 13, 2018
- Exchange
- AMEX
BOUT Options Snapshot
Options pricing data for BOUT is refreshed daily after the close. When listed contracts exist, this page surfaces the latest at-the-money implied volatility, max pain strike, dealer gamma exposure (GEX), and 25-delta skew. Listed contracts and live snapshots appear once the options chain has been published by the exchange for the most recent session.
What This Page Covers
The BOUT overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure.
Frequently asked BOUT overview questions
- What is BOUT?
- BOUT is the ticker symbol for Innovator IBD Breakout Opportunities ETF, an listed exchange-traded fund. The Innovator IBD Breakout Opportunities ETF seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investor's Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the security's recent "resistance level", with consideration for various market conditions. Listed on AMEX. BOUT is the ETF ticker shown on this page; ETF traders use the fund for diversified exposure to its underlying basket, for sector and factor rotation, and for hedging or replication strategies via the listed options chain.
- What are BOUT's key statistics?
- Innovator IBD Breakout Opportunities ETF (BOUT) carries a market capitalization of $16.1M, 52-week range of 34.94-47.21. Full holdings disclosure, expense ratio, and tracking-error history live on the per-ticker fundamentals page or the sponsor's site; daily NAV and premium/discount-to-NAV are accessible from the same view. These structural inputs frame how the ETF options market prices implied volatility relative to its constituents.
- What sector or industry does BOUT belong to?
- Innovator IBD Breakout Opportunities ETF operates in the Financial Services sector, in the Asset Management industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare BOUT's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the BOUT data on this page?
- Options snapshots refresh after each trading session; if no snapshot is currently posted for BOUT, it usually reflects low options liquidity or a recently listed name. Fund-level fields (sponsor, expense ratio, holdings concentration where available) refresh from the vendor feed nightly. ETF-specific filings (N-CSR, N-PX, N-CEN) update on the SEC EDGAR cadence. FINRA microstructure data refreshes on the source's cadence; for ETFs the off-exchange volume signal is dominated by authorized-participant creation and redemption rather than directional flow.